Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has signed a distribution agreement to bring PromarkerD, the world’s first predictive test for diabetic kidney disease, to the Middle East.
Partnership marks the second distribution agreement for the easy-to-use, high volume immunoassay version of the test and comes just weeks after agreement to distribute PromarkerD in Italy.
